Optimizing medication adherence in older persons with hypertension

被引:20
作者
William J. Elliott
机构
[1] RUSH Medical College of RUSH University at RUSH University Medical Center,The Department of Preventive Medicine
关键词
Public Health; Hypertension; Clinical Trial; High Risk; Family Member;
D O I
10.1023/B:UROL.0000025643.80319.b3
中图分类号
学科分类号
摘要
Suboptimal control of hypertension in largecommunities can be attributed, in part, toabout 50% of patients who stop taking theirantihypertensive drugs after 1 year. Older patientswith many illnesses (including chronic kidneydisease) are at especially high risk for discontinuingprescribed medications, but age is a weaker predictor than the number of consumed pills.Determining if medications are being taken asprescribed is difficult, but asking the patientand significant other the simple question,``Have you missed any pills in the last week?''is a good place to start. Despite all theirother virtues, clinical trials seldom providethe same answers regarding medication adherencethat are found in clinical practice.Observational and a few interventional trialshave established that short, simple regimensthat improve patients' symptoms and arewell tolerated are more likely to be takencorrectly. Patient (and family) education isthe cornerstone of improving adherence tomedication, but several other interventionshave also proven useful. There appears to be no``magic bullet'' that will improve medicationadherence in all patients, but providingwritten instructions, simplifying themedication regimen to as few as necessary,once daily, well tolerated and inexpensivepills, involving family members, and promptingpill taking by certain activities of dailyliving all seem to help. Improving medicationadherence would be a simple way to makeantihypertensive therapies much morecost effective, since a medication that is nottaken incurs all of cost, and provides nobenefit to the patient.
引用
收藏
页码:557 / 562
页数:5
相关论文
共 73 条
[1]
Hajjar I(2003)Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000 JAMA 290 199-203
[2]
Kotchen TA.(2000)How well is hypertension controlled in Europe? J Hypertens 18 1348-1349
[3]
Erdine S.(1998)Inadequate management of blood pressure in a hypertensive population N Engl J Med 339 1967-1963
[4]
Berlowitz DR(2002)Interventions to enhance patient adherence to medication prescriptions: scientific review JAMA 288 2868-2879
[5]
Ash AS(2003)Compliance – and improving it – in hypertension P&T Digest 12 56-61
[6]
Hickey C(2002)Helping patients follow prescribed treatment: clinical applications JAMA 288 2880-2883
[7]
McDonald HP(1986)Concurrent and predictive validity of a self-reported measure of medication adherence Medical Care 24 67-74
[8]
Garg AX(1998)Continuation of initial antihypertensive medication after one year of therapy Clin Ther 20 671-681
[9]
Haynes RB.(2001)Fouryear persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes Clin Ther 23 1999-2010
[10]
Elliott WJ.(1998)Changes in antihypertensive therapy – the role of adverse effects and compliance Blood Pressure 7 313-315